Cardiac stem cells are a specialized type of stem cell with the remarkable ability to differentiate into various cell types within the heart, making them a key focus in regenerative medicine for treating cardiovascular diseases. These unique cells reside within the heart tissue and play a crucial role in maintaining cardiac function and repair. Unlike mature heart cells that have limited regenerative capacity, cardiac stem cells possess the potential to generate new heart cells, including cardiomyocytes, endothelial cells, and smooth muscle cells. Researchers are exploring the therapeutic potential of harnessing these cells to repair damaged heart tissue caused by conditions such as heart attacks or heart failure. The hope is that by stimulating the proliferation and differentiation of cardiac stem cells, it may be possible to promote heart regeneration and improve overall cardiac function. Ongoing studies in this field aim to unlock the full potential of cardiac stem cells, offering promising avenues for innovative approaches in cardiovascular treatment and the eventual development of regenerative therapies for heart disorders.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India